EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China

Tongling Xie, Jingyi Meng, Zhe Feng, Yue Gao, Tian Chen, Yalan Chen iD, Jinsong Geng iD

Health Expectations · 2024

DOI: 10.1111/hex.14059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Expectations, 2024. Verfasst von Tongling Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evidence-Based Medicine, Nantong University Medical School, Nantong, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Diabetes Mellitus, Type 2, Decision Making, Shared. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, MOE (Ministry of Education in China) Project of Humanities and Social Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Shared decision‐making (SDM) is a patient‐centred approach to improve the quality of care. An essential requirement for the SDM process is to be fully aware of patient information needs.

Objectives

Our study aimed to assess patient information needs for new antidiabetic medications using the best–worst scaling (BWS) experiment.

Methods

BWS tasks were developed according to a literature review and the focus group discussion. We used a balanced incomplete block design and blocking techniques to generate choice sets. The final BWS contains 11 attributes, with 6‐choice scenarios in each block. The one‐to‐one, face‐to‐face BWS survey was conducted among type 2 diabetic patients in Jiangsu Province. Results were analyzed using count‐based analysis and modelling approaches. We also conducted a subgroup analysis to observe preference heterogeneity.

Results

Data from 539 patients were available for analysis. The most desired information domain was the comparative effectiveness of new antidiabetic medications. It consists of the incidence of macrovascular complications, the length of extended life years, changes in health‐related quality of life, the incidence of microvascular complications, and the control of glycated haemoglobin. Of all the attributes, the incidence of macrovascular complications was the primary concern. Patients' glycemic control and whether they had diabetes complications exerted a significant influence on their information needs.

Conclusions

Information on health benefits is of critical significance for diabetic patients. Patients have different information needs as their disease progresses. Personalized patient decision aids that integrate patient information needs and provide evidence of new antidiabetic medications are worthy of being established. Patient or Public Contribution Before data collection, a pilot survey was carried out among diabetic patients to provide feedback on the acceptability and intelligibility of the attributes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsDiabetes Mellitus, Type 2Decision Making, SharedHumansChinaMaleMiddle AgedFemaleFocus GroupsAgedSurveys and QuestionnairesNeeds AssessmentPatient ParticipationAdult

Stichwörter der Autor:innen

best–worst scalingdiabetesinformation needsshared decision‐making

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Center for Evidence-Based Medicine, Nantong University Medical School, Nantong, China.
  • Information Center, The People's Hospital of Rugao, Nantong, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Rehabilitation Medicine and Clinical Medicine, Medical Institute of Taizhou Polytechnic College, Taizhou, China.

ORCID-Profile: Yalan Chen, Jinsong Geng

Förderung

  • National Natural Science Foundation of China
  • MOE (Ministry of Education in China) Project of Humanities and Social Sciences

Zitieren

APA

Xie, T., Meng, J., Feng, Z., Gao, Y., Chen, T., Chen, Y., & Geng, J. (2024). Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China. Health Expectations. https://doi.org/10.1111/hex.14059

Vancouver

Xie T, Meng J, Feng Z, Gao Y, Chen T, Chen Y, et al. Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China. Health Expectations. 2024. doi:10.1111/hex.14059

BibTeX
@article{Xie2024,
  author = {Xie, Tongling and Meng, Jingyi and Feng, Zhe and Gao, Yue and Chen, Tian and Chen, Yalan and Geng, Jinsong},
  title = {Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China},
  journal = {Health Expectations},
  year = {2024},
  doi = {10.1111/hex.14059}
}
Kostenlos starten →